FrancophonIA/ELRC3.0 huggingface dataset:
English: • if you have tuberculosis.
Slovenian: • če imate tuberkulozo;
English: Correct Incorrect
Slovenian: pravilno nepravilno
English: • if you have long-term or repeated infections.
Slovenian: • če imate katero od dolgotrajnih ali ponavljajočih se okužb;
English: • if you have ever had an allergic reaction to latex.
Slovenian: • če ste imeli kdaj alergijsko reakcijo na lateks
English: These improvements were maintained for 52 weeks (studies 1 and 2).
Slovenian: Navedena izboljšanja so vztrajala 52 tednov (v 1. in 2. študiji).
English: Such signs are listed under “Serious side effects” in section 4.
Slovenian: Omenjeni znaki so navedeni pod naslovom "Resni neželeni učinki" v poglavju 4.
English: Improvements were shown in all components of the ACR scores, including patient assessment of pain.
Slovenian: Do izboljšanja je prišlo pri vseh ocenah po kriterijih ACR, vključno z bolnikovo oceno bolečine.
English: • if you have an active infection which your doctor thinks is important.
Slovenian: • če imate aktivno okužbo, ki se zdi vašemu zdravniku pomembna.
English: • if you have Crohn's disease.
Slovenian: • če imate Crohnovo bolezen;
English: For all of the above indications, available data suggest that a clinical response is usually achieved within 16 weeks of treatment.
Slovenian: Po razpoložljivih podatkih pri vseh zgoraj navedenih indikacijah pride do kliničnega odziva običajno v 16 tednih zdravljenja.
English: Of these, over 11,700 patients were exposed to secukinumab for at least one year.
Slovenian: Med njimi je bilo več kot 11.700 bolnikov izpostavljenih sekukinumabu najmanj eno leto.
English: Quality of life/patient-reported outcomes
Slovenian: Kakovost življenja/izidi po navedbah bolnikov
English: Possible serious infection - the signs may include:
Slovenian: Možnost resne okužbe - znaki lahko vključujejo:
English: • severe allergic reaction with shock (anaphylactic reaction)
Slovenian: • huda alergijska reakcija s šokom (anafilaktična reakcija)
English: The preparation time from piercing the stopper until end of reconstitution takes 20 minutes on average and should not exceed 90 minutes.
Slovenian: Čas priprave od prebadanja zaporke do zaključka rekonstitucije traja v povprečju 20 minut, ne sme pa trajati dlje kot 90 minut.
English: There were no reported cases of more severe neutropenia.
Slovenian: O primerih hujše nevtropenije niso poročali.
English: The safety and efficacy of Cosentyx in children below the age of 18 years have not yet been established.
Slovenian: Varnost in učinkovitost zdravila Cosentyx pri otrocih, starih manj kot 18 let, še nista bili dokazani.
English: Cosentyx is not recommended for children and adolescents (under 18 years of age) because it has not been studied in this age group.
Slovenian: Uporaba zdravila Cosentyx ni priporočljiva za otroke in mladostnike (stare manj kot 18 let), ker je v tej starostni skupini niso proučevali.
English: In addition, one study assessed a chronic treatment regimen versus a “retreatment as needed” regimen [SCULPTURE].
Slovenian: V eni študiji so poleg tega ocenjevali tudi režim kroničnega zdravljenja v primerjavi z režimom "ponovitve zdravljenja po potrebi" [študija SCULPTURE].
English: Your doctor will regularly monitor your condition to check that the treatment is having the desired effect.
Slovenian: Zdravnik bo redno pregledoval vaše stanje in preverjal, ali je zdravljenje tako učinkovito, kot je treba.
English: Serious allergic reaction - the signs may include:
Slovenian: Resne alergijske reakcije - znaki lahko vključujejo:
English: Exposure was dose proportional across all dosing regimens.
Slovenian: Izpostavljenost učinkovini je bila sorazmerna višini odmerka pri vseh režimih odmerjanja.
English: All patients were followed for up to 52 weeks following first administration of study treatment.
Slovenian: Vse bolnike so spremljali do 52 tednov po prvem odmerjanju preučevanega zdravila.
English: Elderly patients (aged 65 years and over) No dose adjustment is required (see section 5.2).
Slovenian: Starejši bolniki (stari 65 let ali več) Prilagajanje odmerkov ni potrebno (glejte poglavje 5.2).
English: Across studies, absolute bioavailabilities in the range between 60 and 77% were calculated.
Slovenian: Po podatkih več študij znaša absolutna biološka uporabnost med 60 % in 77 %.
English: Vials are for single use only.
Slovenian: Viale so samo za enkratno uporabo.
English: Remove the plastic cap from the vial.
Slovenian: Z viale snemite plastični pokrovček.
English: • if you have ulcerative colitis.
Slovenian: • če imate ulcerozni kolitis;
English: Secukinumab has the potential to increase the risk of infections.
Slovenian: Sekukinumab lahko poveča tveganje za razvoj okužb.
English: • if you currently have an infection
Slovenian: • če trenutno prebolevate okužbo
English: • if you are taking, have recently taken or might take any other medicines.
Slovenian: • če jemljete, ste pred kratkim jemali ali pa boste morda začeli jemati katero koli drugo zdravilo,
English: For instructions on reconstitution of the medicinal product before administration, see section 6.6 and the Instructions for Use in the package leaflet.
Slovenian: Za navodila glede rekonstitucije zdravila pred dajanjem glejte poglavje 6.6 in Navodila za uporabo v priloženem navodilu.
English: Chemical and physical in-use stability has been demonstrated for 24 hours at 2ºC to 8ºC.
Slovenian: Kemijsko in fizikalno stabilnost pripravljenega zdravila so dokazali za 24 ur pri 2 °C do 8 °C.
English: In addition, the corresponding frequency category for each adverse drug reaction is based on the following convention: very common (≥1/10); common (≥1/100 to <1/10); uncommon (≥1/1,000 to <1/100); rare (≥1/10,000 to <1/1,000); very rare (<1/10,000); and not known (cannot be estimated from the available data).
Slovenian: Pri tem ustrezna kategorija pogostnosti posameznega neželenega učinka temelji na naslednjem dogovoru: zelo pogosti (≥1/10); pogosti (≥1/100 do <1/10); občasni (≥1/1.000 do <1/100); redki (≥1/10.000 do <1/1.000); zelo redki (<1/10.000) in neznana pogostnost (ni mogoče oceniti iz razpoložljivih podatkov).
English: Week 24
Slovenian: teden 24
English: Improvements in HAQ-DI scores were seen regardless of previous anti-TNFα exposure.
Slovenian: Izboljšanje ocene HAQ-DI so opažali ne glede na predhodno izpostavljenost zaviralcu TNFα.
English: Then talk to your doctor to discuss when you should inject the next dose.
Slovenian: Nato se posvetujte z zdravnikom, kdaj si morate injicirati naslednji odmerek.
English: YOU MUST READ THIS BEFORE INJECTING.
Slovenian: TO MORATE PREBRATI PRED INJICIRANJEM
English: This is intended to aid in the protection of healthcare professionals, patients who self-inject doctor-prescribed medicines, and individuals who assist self-injecting patients from accidental needlestick injuries.
Slovenian: To je namenjeno zaščiti zdravstvenih delavcev, bolnikov, ki si sami injicirajo zdravila, ki jim jih predpiše zdravnik, in oseb, ki bolnikom pomagajo pri samoinjiciranju, pred poškodbami zaradi nehotenega vboda z iglo.
English: • infection of the external ear (otitis externa)
Slovenian: • vnetje zunanjega ušesa (otitis externa)
English: The safety profile of secukinumab is consistent across all indications.
Slovenian: Varnostni profil sekukinumaba je podoben pri vseh indikacijah.
English: Cosentyx can potentially cause serious side effects, including infections and allergic reactions.
Slovenian: Zdravilo Cosentyx lahko povzroči resne neželene učinke, med drugim okužbe in alergijske reakcije.
English: If you have active psoriatic arthritis you will first be given other medicines.
Slovenian: Če imate aktiven psoriatični artritis, boste najprej prejemali druga zdravila.
English: The preparation of the solution for subcutaneous injection must be done without interruption and ensuring that aseptic technique is used.
Slovenian: Pripravljanje raztopine za subkutano injiciranje mora potekati brez prekinitev, izvajati pa ga je treba z aseptično tehniko.
English: Clinically important, active infection, e.g. active tuberculosis (see section 4.4).
Slovenian: Klinično pomembna aktivna okužba, na primer aktivna tuberkuloza (glejte poglavje 4.4).
English: The stream of sterile water for injections should be directed onto the powder.
Slovenian: Tok sterilne vode za injekcije mora biti usmerjen na prašek.
English: ** p values versus etanercept: p=0.0250
Slovenian: ** vrednost p v primerjavi z etanerceptom: p=0,0250
English: Similar responses were seen in PsA study 1.
Slovenian: Podobne odzive so opažali tudi v PsA študiji 1.
English: These improvements were sustained up to week 52.
Slovenian: Ta izboljšanja so se ohranila do konca 52. tedna.
English: Women of childbearing potential should use an effective method of contraception during treatment and for at least 20 weeks after treatment.
Slovenian: Ženske v rodni dobi morajo uporabljati učinkovito kontracepcijo med zdravljenjem in še najmanj 20 tednov po njem.
English: • if you are allergic to secukinumab or any of the other ingredients of this medicine (listed in section 6).
Slovenian: • če ste alergični na sekukinumab ali katero koli sestavino tega zdravila (navedeno v poglavju 6).
English: The data suggest that secukinumab does not suppress the humoral immune response to the meningococcal or influenza vaccines.
Slovenian: Podatki kažejo, da sekukinumab ne zavira humoralnega imunskega odziva na meningokokno cepivo oziroma cepivo proti gripi.
English: The majority of patients also had active psoriasis skin lesions or a documented history of psoriasis.
Slovenian: Večina bolnikov je imela tudi aktivne psoriatične kožne lezije ali dokumentirano anamnezo psoriaze.
English: If you have ankylosing spondylitis you will first be given other medicines.
Slovenian: Če imate ankilozirajoči spondilitis, boste najprej prejemali druga zdravila.
English: • swelling of the face, lips, tongue or throat
Slovenian: • otekanje v obraz, ustnice, jezik ali grlo oziroma žrelo,
English: The efficacy and safety of secukinumab 150 mg and 300 mg were evaluated versus either placebo or etanercept.
Slovenian: Učinkovitost in varnost sekukinumaba v odmerkih 150 mg in 300 mg so vrednotili v primerjavi z bodisi placebom ali etanerceptom.
English: The effect of secukinumab on human fertility has not been evaluated.
Slovenian: Vpliva sekukinumaba na plodnost pri ljudeh niso ocenjevali.
English: For storage conditions after reconstitution of the medicinal product, see section 6.3
Slovenian: Za pogoje shranjevanja po rekonstituciji zdravila glejte poglavje 6.3.
English: Not known (frequency cannot be estimated from the available data): • fungal infections of the skin and mucous membranes (including oesophageal candidiasis)
Slovenian: Neznana pogostnost (ni mogoče oceniti iz razpoložljivih podatkov): • glivične okužbe kože in sluznic (vključno s kandidozo požiralnika)
English: 9/l (CTCAE grade 4) were reported.
Slovenian: 9/l (stopnje 4 po CTCAE).
English: Do not use Cosentyx:
Slovenian: Ne uporabljajte zdravila Cosentyx:
English: Any remaining solution in the vial must not be used and should be discarded in accordance with local requirements.
Slovenian: Morebitnega preostanka raztopine v viali ne smete uporabiti, ampak ga morate zavreči v skladu z lokalnimi zahtevami.
English: Pharmacotherapeutic group: Immunosuppressants, interleukin inhibitors, ATC code: L04AC10
Slovenian: Farmakoterapevtska skupina: Zdravila za zaviranje imunske odzivnosti, zaviralci interlevkinov, oznaka ATC: L04AC10
English: Cosentyx reduces the inflammation and other symptoms of the disease.
Slovenian: Zdravilo Cosentyx zmanjšuje vnetje in druge simptome bolezni.
English: Concomitant immunosuppressive therapy
Slovenian: Sočasno imunosupresivno zdravljenje
English: The powder for solution for injection must be reconstituted before use.
Slovenian: Prašek za raztopino za injiciranje je treba pred uporabo rekonstituirati.
English: From a microbiological point of view, unless the method of reconstitution precludes the risk of microbial contamination, the product should be used immediately.
Slovenian: Z mikrobiološkega stališča je treba zdravilo uporabiti takoj, razen če metoda rekonstitucije izključuje tveganje za kontaminacijo z mikrobi.
English: Allow the vial to stand undisturbed at room temperature for approximately 5 minutes.
Slovenian: Vialo pustite mirovati na sobni temperaturi približno 5 minut.
English: Effect of weight on pharmacokinetics Secukinumab clearance and volume of distribution increase as body weight increases.
Slovenian: Vpliv telesne mase na farmakokinetiko Očistek in volumen porazdelitve sekukinumaba se povečujeta z večanjem telesne mase.
English: If you have forgotten to inject a dose of Cosentyx, inject the next dose as soon as you remember.
Slovenian: Če ste si pozabili injicirati odmerek zdravila Cosentyx, si naslednji odmerek injicirajte takoj, ko to ugotovite.
English: Forty percent of the participants in studies 1 and 2 completed the Psoriasis Symptom Diary©.
Slovenian: Štirideset odstotkov preiskovancev v 1. in 2. študiji je izpolnjevalo dnevnik simptomov psoriaze (Psoriasis Symptom Diary©).
English: What Cosentyx is and what it is used for
Slovenian: Kaj je zdravilo Cosentyx in za kaj ga uporabljamo
English: Table 3 Summary of clinical response on psoriasis study 2 (FIXTURE)
Slovenian: Preglednica 3 Pregled kliničnih odzivov v 2. študiji psoriaze (v študiji FIXTURE)
English: It is not known whether secukinumab is excreted in human milk.
Slovenian: Ni znano, ali se sekukinumab izloča v materino mleko.
English: Patients should be instructed to inject the full amount of Cosentyx according to the instructions provided in the package leaflet.
Slovenian: Bolnikom je treba naročiti, naj si injicirajo celotno količino zdravila Cosentyx po navodilih v priloženem Navodilu za uporabo.
English: • if you are receiving any other treatment for psoriasis, such as another immunosuppressant or phototherapy with ultraviolet (UV) light.
Slovenian: • če prejemate še katerega od zdravil za psoriazo, kot so druga imunosupresivna zdravila, ali se zdravite s fototerapijo (obsevanjem z ultravijoličnimi (UV) žarki).
English: Based on population pharmacokinetic analysis with a limited number of elderly patients (n=71 for age ≥65 years and n=7 for age ≥75 years), clearance in elderly patients and patients less than 65 years of age was similar.
Slovenian: Po rezultatih analize populacijske farmakokinetike pri majhnem številu starejših bolnikov (n=71 za starost ≥65 let in n=7 za starost ≥75 let) je bil očistek pri starejših bolnikih podoben kot pri bolnikih, ki so bili stari manj kot 65 let.
English: Patients randomised to “retreatment as needed” did not achieve adequate maintenance of response and therefore a fixed monthly maintenance regimen is recommended.
Slovenian: Pri bolnikih, ki so bili randomizirani na zdravljenje po režimu "ponovitve zdravljenja po potrebi", se odziv na zdravljenje ni ohranil v zadostni meri, zato se priporoča zdravljenje po vzdrževalnem režimu z rednim mesečnim odmerjanjem zdravila.
English: Cosentyx is intended for use under the guidance and supervision of a physician experienced in the diagnosis and treatment of conditions for which Cosentyx is indicated.
Slovenian: Zdravilo Cosentyx je namenjeno uporabi po navodilih in pod nadzorom zdravnika, ki ima izkušnje z diagnosticiranjem in zdravljenjem bolezni, za katere je indicirano zdravilo Cosentyx.
English: Other medicines and Cosentyx
Slovenian: Druga zdravila in zdravilo Cosentyx
English: Some patients with an initial partial response may subsequently improve with continued treatment beyond 16 weeks.
Slovenian: Pri tistih bolnikih, pri katerih sprva pride le do delnega odziva, se ta lahko kasneje izboljša, če bolnik prejema zdravilo več kot 16 tednov.
English: Figure 1 Time course of percentage change from baseline of mean PASI score in study 1 (ERASURE)
Slovenian: Slika 1 Časovni potek odstotne spremembe povprečne vrednosti indeksa PASI od izhodišča v 1. študiji (študiji ERASURE)
English: • burning sensation when passing urine.
Slovenian: • pekočo bolečino pri odvajanju urina.
English: In a study in subjects with plaque psoriasis, no interaction was observed between secukinumab and midazolam (CYP3A4 substrate).
Slovenian: V študiji pri bolnikih s psoriazo v plakih niso opažali nobenih interakcij med sekukinumabom in midazolamom (substrat CYP3A4).
English: Immunoglobulins are excreted in human milk and it is not known if secukinumab is absorbed systemically after ingestion.
Slovenian: Imunoglobulini se izločajo v materino mleko, ni pa znano, ali se sekukinumab po zaužitju sistemsko absorbira.
English: Secukinumab is a recombinant fully human monoclonal antibody produced in Chinese Hamster Ovary (CHO) cells.
Slovenian: Sekukinumab je rekombinantno popolnoma humano monoklonsko protitelo, pridobljeno s pomočjo ovarijskih celic kitajskega hrčka (celic CHO).
English: • lower respiratory tract infections
Slovenian: • okužbe spodnjih dihal,
English: If an anaphylactic or other serious allergic reactions occur, administration of secukinumab should be discontinued immediately and appropriate therapy initiated.
Slovenian: Če pride do anafilaktičnih ali drugih resnih alergijskih reakcij, je treba zdravljenje s sekukinumabom takoj prekiniti in uvesti ustrezno zdravljenje.
English: (nasopharyngitis, rhinitis)
Slovenian: (nazofaringitis in rinitis).
English: In psoriasis phase 3 clinical studies, neutropenia was more frequently observed with secukinumab than with placebo, but most cases were mild, transient and reversible.
Slovenian: V kliničnih študijah psoriaze faze 3 so nevtropenijo pri uporabi sekukinumaba opažali pogosteje kot pri uporabi placeba, vendar je bila v večini primerov blago izražena, prehodna in reverzibilna.
English: • warm, red and painful skin, or a painful skin rash with blisters
Slovenian: • vročo, rdečo in bolečo kožo ali boleč kožni izpuščaj z mehurčki,
English: Cosentyx is used for the treatment of the following inflammatory diseases:
Slovenian: Zdravilo Cosentyx uporabljamo pri zdravljenju naslednjih vnetnih bolezni:
English: • if you have recently had a vaccination or if you are due to have a vaccination during treatment with Cosentyx.
Slovenian: • če ste bili pred kratkim cepljeni ali če morate prejeti cepivo v času zdravljenja z zdravilom
English: IL-17A is a naturally occurring cytokine that is involved in normal inflammatory and immune responses.
Slovenian: IL-17A je naravno prisoten citokin, ki sodeluje pri normalnem vnetnem in imunskem odzivu.
English: Table 4 Summary of clinical response on CLEAR study
Slovenian: Preglednica 4 Pregled kliničnih odzivov v študiji CLEAR
English: In the event of overdose, it is recommended that the patient be monitored for any signs or symptoms of adverse reactions and appropriate symptomatic treatment be instituted immediately.
Slovenian: V primeru prevelikega odmerjanja je priporočeno bolnika opazovati glede morebitnega pojavljanja znakov ali simptomov neželenih učinkov in v tem primeru takoj uvesti simptomatsko zdravljenje.
English: ASAS 5/6, %
Slovenian: odziv ASAS 5/6, %
English: For other psoriatic arthritis patients:
Slovenian: Za druge bolnike s psoriatičnim artritisom:
English: Consideration should be given to discontinuing treatment in patients who have shown no response by 16 weeks of treatment.
Slovenian: Pri bolnikih, pri katerih v 16 tednih zdravljenja ne pride do odziva, je treba razmisliti o prenehanju zdravljenja.
English: Because of the potential for adverse reactions in nursing infants from secukinumab, a decision on whether to discontinue breast-feeding during treatment and up to 20 weeks after treatment or to discontinue therapy with Cosentyx must be made taking into account the benefit of breast-feeding to the child and the benefit of therapy to the woman.
Slovenian: Zaradi možnosti razvoja neželenih učinkov sekukinumaba pri dojenem otroku se je treba odločiti, ali bo bolnica prenehala z dojenjem v času zdravljenja in obdobju 20 tednov po zaključku zdravljenja ali bo prekinila zdravljenje z zdravilom Cosentyx, pri čemer je treba pretehtati prednosti dojenja za otroka in prednosti zdravljenja za mater.
English: Patients receiving secukinumab may receive concurrent inactivated or non-live vaccinations.
Slovenian: Bolniki, ki prejemajo sekukinumab, so lahko sočasno cepljeni z inaktiviranimi ali drugimi cepivi, ki niso živa.
English: Animal studies have not been conducted to evaluate the carcinogenic potential of secukinumab.
Slovenian: Za oceno kancerogenega potenciala sekukinumaba niso izvajali študij na živalih.
English: CARTON - vial
Slovenian: ŠKATLA - viala
English: Do not shake or invert the vial.
Slovenian: Viale ne stresajte in ne obračajte.
English: Neutropenia <1.0-0.5x10
Slovenian: O nevtropeniji z vrednostmi <1,0-0,5 x 10
English: For both studies, the primary endpoint was at least a 20% improvement in Assessment of Spondyloarthritis International Society (ASAS 20) criteria at week 16.
Slovenian: V obeh študijah je bil primarni cilj študije najmanj 20-odstotno izboljšanje ocene ASAS (ASAS 20) po kriterijih Mednarodnega združenja za spondiloartritis (ASAS - Assessment of Spondyloarthritis International Society) po 16 tednih zdravljenja.
English: IgGs are mainly eliminated via catabolism and hepatic impairment is not expected to influence clearance of secukinumab.
Slovenian: Protitelesa IgG se izločajo večinoma s pomočjo katabolizma in ni pričakovati, da bi okvara jeter lahko vplivala na izločanje sekukinumaba iz telesa.
English: Patients in Ankylosing Spondylitis study 1 (AS study 1) and Ankylosing Spondylitis study 2 (AS study 2) had a diagnosis of AS for a median of 2.7 to 5.8 years.
Slovenian: Pri bolnikih v študiji ankilozirajočega spondilitisa 1 (AS študiji 1) in študiji ankilozirajočega spondilitisa 2 (AS študiji 2) je bila mediana časa od postavitve diagnoze ankilozirajočega spondilitisa 2,7 do 5,8 let.
English: Patients should be instructed to seek medical advice if signs or symptoms suggestive of an infection occur.
Slovenian: Bolnikom je treba naročiti, da se posvetujejo z zdravnikom, če opazijo znake ali simptome, ki kažejo na okužbo.
English: How much Cosentyx is given and for how long Your doctor will decide how much Cosentyx you need and for how long.
Slovenian: Koliko zdravila Cosentyx je treba dajati in kako dolgo Koliko zdravila Cosentyx potrebujete in kako dolgo, bo določil vaš zdravnik.
English: If you think you may be allergic, ask your doctor for advice before using Cosentyx.
Slovenian: Če menite, da bi lahko bili alergični, se pred začetkom uporabe zdravila Cosentyx posvetujte z zdravnikom.
English: What you need to know before you use Cosentyx
Slovenian: Kaj morate vedeti, preden boste uporabili zdravilo Cosentyx
English: methionine, polysorbate 80 and water for injections.
Slovenian: polisorbat 80 in voda za injekcije.
English: Table 6 Change in modified Total Sharp Score in psoriatic arthritis
Slovenian: Preglednica 6 Sprememba modificirane skupne Sharpove ocene pri psoriatičnem artritisu
English: Approximately 15 to 25% of patients in phase III studies had psoriatic arthritis (PsA) at baseline.
Slovenian: Približno 15 do 25 % bolnikov v študijah faze III je imelo ob izhodišču psoriatični artritis.
English: Patient Instructions for Use
Slovenian: Navodila za uporabo za bolnike
English: Secukinumab has been shown to lower (within 1 to 2 weeks of treatment) levels of C-reactive protein, which is a marker of inflammation.
Slovenian: Dokazali so, da sekukinumab (v roku 1 do 2 tednov zdravljenja) zniža koncentracijo C-reaktivnega proteina, ki je označevalec vnetja.
English: Prepare the required number of vials (2 vials for the 300 mg dose).
Slovenian: Pripravite potrebno število vial (2 viali za odmerek 300 mg).
English: After using Cosentyx you should not breast-feed for at least 20 weeks after the last dose.
Slovenian: Po prenehanju uporabe zdravila Cosentyx še najmanj 20 tednov po zadnjem odmerku ne smete dojiti.
English: Table 1 List of adverse reactions in clinical studies and post-marketing experience
Slovenian: Preglednica 1 Seznam neželenih učinkov v kliničnih študijah in na osnovi izkušenj uporabe zdravila po prihodu na trg
English: Cosentyx is available in packs containing one vial.
Slovenian: Zdravilo Cosentyx je na voljo v pakiranju, ki vsebuje eno vialo.